Article Details

Revolution Medicines (NASDAQ:RVMD) Stock Price Expected to Rise, The Goldman Sachs ...

Retrieved on: 2025-09-14 15:38:34

Tags for this article:

Click the tags to see associated articles and topics

Revolution Medicines (NASDAQ:RVMD) Stock Price Expected to Rise, The Goldman Sachs .... View article details on hiswai:

Excerpt

The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group's price objective suggests a potential upside of 56.82% from the ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo